FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079168295> ?p ?o ?g. }

• W2079168295 endingPage "1624" @default.
• W2079168295 startingPage "1615" @default.
• W2079168295 abstract "Chronic hepatitis C virus (HCV) infection cases resistant to conventional therapies might be treated by immunotherapy as cytotoxic T lymphocytes (CTL) are the main mechanism through which viral infections are cleared. The HCV core gene, with the highest homology between HCV types, deleted of its autoimmune-stimulating regions (pseudo-GOR and pseudo-p450), may be an appropriate antigen for targeting HCV-infected cells. Two recombinant adeno-associated virus (rAAV) vectors, carrying either the full length (aa 1–190) or truncated (aa 49–180, deleted of the pseudo-GOR and pseudo-p450 sequences) versions of core, were generated. Both AAV/core (l–190) and AAV/core (49–180) were used to transduce/load dendritic cells (DC) at high levels (88–95%). These two genetically altered DC types then stimulated anti-core CTL. The DC and CTL were analyzed by FACS and for killing efficiency (percent target killing). The rAAV-altered DC displayed higher levels of CD80, CD83, CD86, and CD 1a than control DC. The truncated core (aa 49–180) gene stimulated equivalent and strong killing of synthetic core-positive autologous peripheral blood lymphocyte (PBL) targets to that stimulated by the full length core gene. However, the smaller core (49–180) antigen gene stimulated lower levels of killing of core-negative “self” PBL targets (GOR- and p450-positive) (p = 0.002). These AAV/core: DC-stimulated CTL displayed higher IFN-γ expression, higher CD8:CD4 ratios, and lower CD56:CD8 ratios than controls. The rAAV-loading derived CD8+ T cells had more CD69+ cells and the CD4+ T populations had fewer CD25+ cells than controls. We conclude that the core (49–180) gene is an effect antigen, but has the advantage of stimulating less self-recognition. Thus, core (49–180) may be useful for further translational immunotherapy studies against HCV." @default.
• W2079168295 created "2016-06-24" @default.
• W2079168295 creator A5001277349 @default.
• W2079168295 creator A5033299593 @default.
• W2079168295 creator A5035629432 @default.
• W2079168295 creator A5036687874 @default.
• W2079168295 creator A5036711179 @default.
• W2079168295 creator A5038068859 @default.
• W2079168295 creator A5056813172 @default.
• W2079168295 creator A5066330334 @default.
• W2079168295 creator A5084575560 @default.
• W2079168295 creator A5088014089 @default.
• W2079168295 date "2006-03-06" @default.
• W2079168295 modified "2023-09-28" @default.
• W2079168295 title "An autoimmune domain-reduced HCV core gene remains effective in stimulating anti-core cytotoxic T lymphocyte activity" @default.
• W2079168295 cites W118298973 @default.
• W2079168295 cites W124239641 @default.
• W2079168295 cites W1509098294 @default.
• W2079168295 cites W1623078040 @default.
• W2079168295 cites W1697313167 @default.
• W2079168295 cites W1826967025 @default.
• W2079168295 cites W1975460646 @default.
• W2079168295 cites W1986308869 @default.
• W2079168295 cites W1988670888 @default.
• W2079168295 cites W1990058709 @default.
• W2079168295 cites W1995994587 @default.
• W2079168295 cites W2010244581 @default.
• W2079168295 cites W2012308482 @default.
• W2079168295 cites W2016032078 @default.
• W2079168295 cites W2017683315 @default.
• W2079168295 cites W2028804867 @default.
• W2079168295 cites W2031100151 @default.
• W2079168295 cites W2033040724 @default.
• W2079168295 cites W2044421329 @default.
• W2079168295 cites W2046178003 @default.
• W2079168295 cites W2049091591 @default.
• W2079168295 cites W2058913846 @default.
• W2079168295 cites W2062249345 @default.
• W2079168295 cites W2065006357 @default.
• W2079168295 cites W2065594131 @default.
• W2079168295 cites W2074283878 @default.
• W2079168295 cites W2078231720 @default.
• W2079168295 cites W2086383324 @default.
• W2079168295 cites W2088733641 @default.
• W2079168295 cites W2117590388 @default.
• W2079168295 cites W2124376809 @default.
• W2079168295 cites W2127296931 @default.
• W2079168295 cites W2133049098 @default.
• W2079168295 cites W2136340581 @default.
• W2079168295 cites W2158285748 @default.
• W2079168295 cites W2160798380 @default.
• W2079168295 cites W2181165975 @default.
• W2079168295 cites W2185501589 @default.
• W2079168295 cites W2320323123 @default.
• W2079168295 cites W2365256941 @default.
• W2079168295 cites W2420546279 @default.
• W2079168295 cites W2436751633 @default.
• W2079168295 cites W95851814 @default.
• W2079168295 cites W965054658 @default.
• W2079168295 doi "https://doi.org/10.1016/j.vaccine.2005.09.055" @default.
• W2079168295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16289277" @default.
• W2079168295 hasPublicationYear "2006" @default.
• W2079168295 type Work @default.
• W2079168295 sameAs 2079168295 @default.
• W2079168295 citedByCount "12" @default.
• W2079168295 countsByYear W20791682952012 @default.
• W2079168295 countsByYear W20791682952014 @default.
• W2079168295 countsByYear W20791682952019 @default.
• W2079168295 crossrefType "journal-article" @default.
• W2079168295 hasAuthorship W2079168295A5001277349 @default.
• W2079168295 hasAuthorship W2079168295A5033299593 @default.
• W2079168295 hasAuthorship W2079168295A5035629432 @default.
• W2079168295 hasAuthorship W2079168295A5036687874 @default.
• W2079168295 hasAuthorship W2079168295A5036711179 @default.
• W2079168295 hasAuthorship W2079168295A5038068859 @default.
• W2079168295 hasAuthorship W2079168295A5056813172 @default.
• W2079168295 hasAuthorship W2079168295A5066330334 @default.
• W2079168295 hasAuthorship W2079168295A5084575560 @default.
• W2079168295 hasAuthorship W2079168295A5088014089 @default.
• W2079168295 hasConcept C147483822 @default.
• W2079168295 hasConcept C147969180 @default.
• W2079168295 hasConcept C153911025 @default.
• W2079168295 hasConcept C154317977 @default.
• W2079168295 hasConcept C159047783 @default.
• W2079168295 hasConcept C167672396 @default.
• W2079168295 hasConcept C202751555 @default.
• W2079168295 hasConcept C203014093 @default.
• W2079168295 hasConcept C2778297628 @default.
• W2079168295 hasConcept C39347974 @default.
• W2079168295 hasConcept C55493867 @default.
• W2079168295 hasConcept C86803240 @default.
• W2079168295 hasConceptScore W2079168295C147483822 @default.
• W2079168295 hasConceptScore W2079168295C147969180 @default.
• W2079168295 hasConceptScore W2079168295C153911025 @default.
• W2079168295 hasConceptScore W2079168295C154317977 @default.
• W2079168295 hasConceptScore W2079168295C159047783 @default.
• W2079168295 hasConceptScore W2079168295C167672396 @default.
• W2079168295 hasConceptScore W2079168295C202751555 @default.

• next